Mounjaro Tirzepatide 7.5mg KwikPen for Diabetes & Weight Management

Mounjaro 7.5mg KwikPen contains Tirzepatide, a prescription once-weekly injection for adults managing type 2 diabetes.

This mid-range strength also supports chronic weight management in suitable adults alongside a healthy diet and physical activity.

• Contains Tirzepatide 7.5mg for blood sugar and weight support

• Once-weekly subcutaneous injection prescribed for adults

• Helps improve blood sugar control in type 2 diabetes

• Supports appetite control and healthy weight reduction

• Dual GIP and GLP-1 receptor agonist

• KwikPen design for easy weekly self-injection

Benefits:

• Helps manage blood sugar levels day to day

• Supports healthy weight management in suitable adults

• Helps reduce appetite and portion sizes

• Promotes convenient once-weekly dosing

• Helps improve glycemic control

• Assists dose step-up as advised by your doctor

• Supports treatment alongside diet and exercise

How to Use:

• Use only as prescribed by your doctor.

• Inject 7.5mg once weekly using the KwikPen.

• Inject under the skin.

• Rotate injection sites.

• Use on the same day each week.

• Follow your prescribed dose schedule.